arrow
R

René Rodrı́guez

instituto de investigacion sanitaria del principado de asturias
H指数:31
被引数:3,544

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancing in Sarcoma 3D Modeling: Identification of SRC as an Actionable Vulnerability in Doxorubicin-Resistant Osteosarcoma Organoids

肉瘤三维建模的进展:在阿霉素耐药性成骨肉瘤类器官中鉴定SRC为可操作易损靶点

MedComm
IF10.7
2026-11-130
OAAI
Retraction notice to "Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways" [Biomedicine & Pharmacotherapy 161 (2023) 114512]

撤稿声明:"通过PI3K/PTEN和MEK/ERK通路靶向头颈鳞状细胞癌中miR-301a的致癌功能" [Biomedicine & Pharmacotherapy 161 (2023) 114512]

2026-06-170
OA
Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma

脂质体介导的钌基金属药物递送以克服骨肉瘤中的顺铂耐药性

2026-05-110
OA
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
2023-06-0815
OAAI
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
2020-11-1718
OAAI
Sarcoma treatment in the era of molecular medicine

分子医学时代的肉瘤治疗

2020-10-13173
OAAI
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
2019-08-0217
OAAI